Thomas Anderson
CIK 1612903 · See Remarks · last filed 2025-05-30
Thomas Anderson is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for ZVRA, was dated May 30, 2025. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $253.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$253.0K
2
14
-$1.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Director | 20,000 | $12.65 | $253.0K | $116.8K | 5 | 2025-05-30 |
| Sage Therapeutics, Inc. (SAGE) Delisted | See Remarks | 1,900 | $8.68 | $16.5K | -$1.28M | 9 | 2017-02-08 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-30 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2024-07-16 | ZVRA | Buy (P) | +10,000 | $68.1K | EDGAR |
| 2024-05-15 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2023-09-06 | ZVRA | Buy (P) | +10,000 | $48.8K | EDGAR |
| 2023-08-25 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2017-02-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-19 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +1,554 | -$3 | EDGAR |
| 2016-12-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-28 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | — | -$460.8K | EDGAR |
| 2016-02-10 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |